Literature DB >> 5416172

Quantification of the binding tendencies of cholestyramine. II. Mechanism of interaction with bile salt and fatty acid salt anions.

W H Johns, T R Bates.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5416172     DOI: 10.1002/jps.2600590311

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  8 in total

1.  The effect of cholestyramine on intestinal absorption.

Authors:  R J West; J K Lloyd
Journal:  Gut       Date:  1975-02       Impact factor: 23.059

2.  Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea.

Authors:  R N Appleby; A Bajor; P-G Gillberg; H Graffner; M Simrén; K A Ung; Jrf Walters
Journal:  United European Gastroenterol J       Date:  2016-07-26       Impact factor: 4.623

Review 3.  Pruritus associated with cholestasis. A review of pathogenesis and management.

Authors:  M Khandelwal; P F Malet
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

4.  Equilibrium and kinetic factors influencing bile sequestrant efficacy.

Authors:  P E Luner; G L Amidon
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

5.  Cholestyramine in treatment of postvagotomy diarrhoea--double-blind controlled trial.

Authors:  J G Allan; R I Russell
Journal:  Br Med J       Date:  1977-03-12

6.  Pruritic effect of bile salts.

Authors:  J Kirby; K W Heaton; J L Burton
Journal:  Br Med J       Date:  1974-12-21

7.  Bile acids and vitamin A absorption in man: the effects of two bile acid-binding agents, cholestyramine and lignin.

Authors:  D L Barnard; K W Heaton
Journal:  Gut       Date:  1973-04       Impact factor: 23.059

8.  Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.

Authors:  J H Caldwell; N J Greenberger
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.